Skip to main content

. 1992 May 9;304(6836):1225. doi: 10.1136/bmj.304.6836.1225

Rhabdomyolysis due to combined treatment with lovastatin and cholestyramine.

C Chrysanthopoulos ¹, N Kounis ¹

PMCID: PMC1881805 PMID: 1515796

1225

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Kogan A. D., Orenstein S. Lovastatin-induced acute rhabdomyolysis. Postgrad Med J. 1990 Apr;66(774):294–296. doi: 10.1136/pgmj.66.774.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
Maher V. M., Pappu A., Illingworth D. R., Thompson G. R. Plasma mevalonate response in lovastatin-related myopathy. Lancet. 1989 Nov 4;2(8671):1098–1098. doi: 10.1016/s0140-6736(89)91109-4. [DOI] [PubMed] [Google Scholar]
Marais G. E., Larson K. K. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy. Ann Intern Med. 1990 Feb 1;112(3):228–230. doi: 10.7326/0003-4819-112-3-228. [DOI] [PubMed] [Google Scholar]
Walravens P. A., Greene C., Frerman F. E. Lovastatin, isoprenes, and myopathy. Lancet. 1989 Nov 4;2(8671):1097–1098. doi: 10.1016/s0140-6736(89)91108-2. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES